Clinical trial
Prevention and Treatment of Epstein-Barr Virus (EBV) Lymphoma Following a Solid…
NCT00058604 · Baylor College of Medicine, Other · Completed
Key facts
| NCT number | NCT00058604 |
|---|---|
| Title | Prevention and Treatment of Epstein-Barr Virus (EBV) Lymphoma Following a Solid Organ Transplant Using EBV Specific Cytotoxic T Lymphocytes (CTLs). |
| Official title | Autologous EBV Specific CTLs for Prophylaxis and Therapy of EBV Lymphoma Post Solid Organ Transplant |
| Acronym | EUCLID |
| Lead sponsor | Baylor College of Medicine, Other |
| Collaborators | The Methodist Hospital Research Institute Center for Cell and Gene Therapy, Baylor College of Medicine |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Epstein-Barr Virus Infections, Lymphoproliferative Disorders |
| Intervention type | Biological |
| Interventions | Intravenous injection of EBV specific CTLs |
| Enrollment | 12 |
| Start date | Jan 1, 2001 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Apr 9, 2003 |
| Last update posted | Jan 18, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: